Search clinical trials for: H1 antihistamines

Total 1148 results

Johanna Maria Vermeulen
Nanjing University of Chinese Medicine; Mermaid Medicine®

Completed

Acupuncture for Nasal Congestion in Allergic Rhinitis (ANCAR)

Allergic Rhinitis

Netherlands
Bayside Health

Completed

Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis

Allergic Rhinitis

Australia
Sanofi
Regeneron Pharmaceuticals

Active, not recruiting

Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)

Chronic Spontaneous Urticaria

China, France, Spain, Argentina, Germany, Japan, United States, Canada, Hungary, Russian Federation, United Kingdom
Sanofi
Regeneron Pharmaceuticals

Completed

Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)

Cold Urticaria

United States, Argentina, Canada, Germany, Japan
Goldman, Butterwick, Fitzpatrick and Groff
DUSA Pharmaceuticals, Inc.

Completed

A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy

Actinic Keratoses

United States
Gachon University Gil Medical Center
Hallym University Medical Center; Hallym University Kangnam Sacred Heart Hospital and other collaborators

Recruiting

Concomitant Intranasal Antihistamine and Corticosteroid in Stepwise Treatment Strategy for Allergic Rhinitis (INCS/INAH)

Allergic Rhinitis

Korea, Republic of
Consorci Sanitari de Terrassa
Institut Català de la Salut; Fundacio d'Investigacio en Atencio Primaria Jordi...

Recruiting

Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection

COVID19 | ACE Inhibitors | ARB | Influenza Vaccination | Amantadine | Antihistamine Allergy

Spain
University of Cincinnati

Unknown

Prevalence of Antihistamine Responsive Irritable Bowel Syndrome With Diarrhea

Irritable Bowel Syndrome | Dermatographism | Post-prandial Diarrhea
National Institute on Deafness and Other Communication...

Completed

Acute Otitis Media: Adjuvant Therapy to Improve Outcome

Otitis Media

United States
Eisai Co., Ltd.

Active, not recruiting

Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

Breast Neoplasms

Japan
University of Oregon

Recruiting

Histamine as a Molecular Transducer of Adaptation to Exercise

Postexercise Hypotension

United States
Chongqing Medical University

Recruiting

Prospective Multicenter Observational Study and Promotion of the Application of Focused Ultrasound in Allergic Rhinitis

Allergic Rhinitis

China
Consorci Sanitari de Terrassa
Institut Català de la Salut

Recruiting

Antihistamines, Amantadine and Evolution of the SARS-CoV-2 Infection

COVID-19

Spain
Vanderbilt University

Withdrawn

Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops

Endolymphatic Hydrops | Eustachian Tube Dysfunction

United States
Chulalongkorn University

Active, not recruiting

Antiplatelet Therapy in Chronic Urticaria

Chronic Urticaria

Thailand
Genentech, Inc.

Completed

A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists

Chronic Idiopathic Urticaria

Germany, United Kingdom, United States, Switzerland, Australia, New Zealand, Poland, Singapore
Benha University

Recruiting

Effects of Systemic Drugs on Intraocular Pressure

Hypertension | Glaucoma, Angle-Closure | Glaucoma Suspect | Glaucoma Secondary to Drugs, Bilateral

Egypt
BeerYaakov Mental Health Center
Weizmann Institute of Science

Unknown

Transcranial Magnetic Stimulation (TMS) in Schizophrenia

Schizophrenia

Israel
Erasmus Medical Center

Not yet recruiting

Evaluation of the Omission of Dexamethasone in Premedication Regimens During Paclitaxel Treatment (DEXASTOP)

Cancer

Netherlands
Hamilton Health Sciences Corporation
McMaster University; AllerGen NCE Inc.

Completed

Peanut Allergy Oral Immunotherapy Desensitization

Peanut Allergy

Canada
China Medical University Hospital

Completed

Anti-histamines Promote Electroacupuncture Analgesia: Basic and Clinical Research

Pain

Taiwan
Genentech, Inc.

Completed

Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)

Multiple Sclerosis, Primary Progressive | Relapsing Multiple Sclerorsis

United States, Germany, Canada, Sweden
Genentech, Inc.

Completed

A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)

Chronic Idiopathic Urticaria
University of Sao Paulo
Brainsway

Completed

Treatment of Bipolar Depression With H1-Coil Deep Brain rTMS: Clinical-Cognitive and Safety Evaluation (rTMSH1Coil)

Bipolar Depression

Brazil
Centre for Addiction and Mental Health
Canadian Institutes of Health Research (CIHR); Brainsway

Completed

Deep rTMS for Treatment-Resistant Late-life Depression (rTMS)

Major Depressive Disorder

Canada
Embody Orthopaedic Limited
Imperial College London

Active, not recruiting

H1 Hip Resurfacing Arthroplasty (H1HRA)

Hip Dysplasia | Hip Osteoarthritis | Hip Necrosis

United Kingdom
Shanghai Mental Health Center

Recruiting

Exploration of the Deep Transcranial Magnetic Stimulation for Treatment Resistant Schizophrenia

Treatment Resistant Schizophrenia Based on the DTMS

China
Shalvata Mental Health Center

Completed

Evaluation of the H-Coil Transcranial Magnetic Stimulation (TMS) Device in the Treatment of Bipolar Depression

Bipolar Depression

Israel
Brainsway

Unknown

Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD)

Major Depressive Disorder (MDD)

United States, Canada, Israel
Shalvata Mental Health Center

Unknown

Tolerability, Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia

Schizophrenia

Israel
Shalvata Mental Health Center

Unknown

A Prospective Trial to Explore the Efficacy of dTMS in Subjects With Fibromyalgia

Fibromyalgia

Israel
Shalvata Mental Health Center

Unknown

dTMS as a Treatment for Patients With Fibromyalgia

Studying Efficacy of dTMS in FM
University of California, San Diego

Recruiting

Transcranial Magnetic Stimulation (TMS) in the Treatment of Anorexia Nervosa

Anorexia Nervosa

United States
Rotman Research Institute at Baycrest
Centre for Addiction and Mental Health; Brainsway

Recruiting

Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults

Alzheimer Disease | Mild Cognitive Impairment | Major Depressive Disorder

Canada
Shalvata Mental Health Center
Brainsway

Completed

Evaluation of Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression

Major Depression

Israel
Embody Orthopaedic Limited
Imperial College London; National Institute for Health Research, United Kingdom

Not yet recruiting

The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement (ACTIVE)

Inflammatory Arthritis | Osteoarthritis, Hip
Vaxess Technologies
ICON plc; Q2 Solutions; Centricity Research

Completed

Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP

Influenza

Canada
GlaxoSmithKline

Terminated

Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris

Pemphigus

United States
Khon Kaen University

Unknown

Intralesional Bevacizumab Injection on Primary Pterygium (bevacizumab)

Inflammation | Pterygium

Thailand
St George's, University of London
Novartis Vaccines; Statens Serum Institut; European Union

Terminated

A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6) (TMUVA-01)

Tuberculosis

United Kingdom
Vaxart

Completed

Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults

Seasonal Influenza Preventative Vaccine Pharmacodynamics

United States
University Ghent
Research Foundation Flanders

Recruiting

The Role of Histamine in Muscle Protein Synthesis Following Resistance Training

Histamine

Belgium
Arrowhead Pharmaceuticals

Terminated

Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection

Hepatitis B

Korea, Republic of, Germany, China
Shalvata Mental Health Center

Unknown

A Randomized Sham-Controlled Study of H-Coil Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Late-Life Depression

Depression

Israel
Erasmus Medical Center
Sanofi

Active, not recruiting

Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs) (CABA-V7)

Metastatic Prostate Cancer | Circulating Tumor Cell

Netherlands
Shalvata Mental Health Center

Unknown

Evaluation of the H-Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for Treatment of Major Depressive Episode in the Elderly

Depression

Israel
University Hospital, Tours

Completed

Methotrexate in the Treatment of Chronic Idiopathic Urticaria (MUCIS)

Chronic Urticaria

France
GlaxoSmithKline

Completed

Drug Use Investigation for XYZAL®

Rhinitis, Allergic, Perennial and Seasonal
UCB Pharma

Completed

POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)

Seasonal Allergic Rhinitis
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)

Multiple Sclerosis

United States, Brazil, Poland, United Kingdom, Turkey, Bulgaria, Belgium, Canada, Denmark, France, Germany, Greece, Hungary, Italy, Peru, Portugal, Russian Federation, Spain, Switzerland, Ukraine, Mexico, Argentina

Search clinical trials for: H1 antihistamines

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations